A Study of Zetomipzomib (KZR-616) in Patients With Autoimmune Hepatitis (PORTOLA) (clinicaltrials.gov) - Aug 19, 2024 - P2 | N=24 | Active, not recruiting | Sponsor: Kezar Life Sciences, Inc. | Recruiting ➔ Active, not recruiting
Enrollment closed • Autoimmune Hepatitis • Hepatology • Immunology • Inflammation
|